common variants
number of variants
stages of Treatment REsistance
common genetic variants
Treatment challenges
treatment choices
single variants
relevant variants
MDD patients
role of rare variants
different patients
stages of resistance
best treatment strategy
TRD genetic markers
genetic finding
genetics of TRD
number of failed treatments
emerging healthcare problem of Treatment Resistant Depression
project
Exome Sequencing
clinical burden
prospective clinical trial
personalised medicine study
findings
impact of clinical variables
development of new evidence-based treatments
Preliminary evidence
different biological dysfunctions
Major Depressive Disorder
Previous pharmacogenetic studies
genome-wide genotyping
unique GSRD sample
cost-effectiveness
time
cumulative effect
Antidepressants
lack of biomarkers available
functionality
genes
pathways
work
antidepressant response
genomic profile
choice of anti-depressants
essential step
days
disability
EU
analysis
funding sources